Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688013's Return-on-Tangible-Asset is ranked better than 88.51% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.76
vs SHSE:688013: 12.99
Touchstone International Medical Science Co (SHSE:688013) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Touchstone International Medical Science Co Return-on-Tangible-Asset Related Terms
Touchstone International Medical Science Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co Return-on-Tangible-Asset Chart
Touchstone International Medical Science Co Annual Data
SHSE:688013 vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Touchstone International Medical Science Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touchstone International Medical Science Co Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Touchstone International Medical Science Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Touchstone International Medical Science Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.03% mean?
Touchstone International Medical Science Co (SHSE:688013) has a Return-on-Tangible-Asset of 6.03% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Touchstone International Medical Science Co and its competitors. This is 48% below median its historical median of 11.58. Over the past decade, Touchstone International Medical Science Co's Return-on-Tangible-Asset has ranged from 8.09 to 35.76. According to the industry distribution chart, Touchstone International Medical Science Co ranks #98 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 11.5%.
Is Touchstone International Medical Science Co's Return-on-Tangible-Asset too high?
Touchstone International Medical Science Co's current Return-on-Tangible-Asset of 6.03% is 48% below median its 10-year median of 11.58. Over the past 10 years, this metric has ranged from a low of 8.09 to a high of 35.76. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.76. Touchstone International Medical Science Co's value of 6.03% is 693.4% above this industry median. Based on the distribution chart, Touchstone International Medical Science Co ranks #98 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Touchstone International Medical Science Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touchstone International Medical Science Co's Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Touchstone International Medical Science Co ranks #98 out of 853 companies for Return-on-Tangible-Asset. This places Touchstone International Medical Science Co in the top 12% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.76. Touchstone International Medical Science Co's value of 6.03% is 693.4% above this benchmark. Historically, Touchstone International Medical Science Co's own Return-on-Tangible-Asset has ranged from 8.09 to 35.76 over the past decade. While the company's 10-year median is 11.58 vs. the industry median of 0.76, Touchstone International Medical Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.76, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touchstone International Medical Science Co's current Return-on-Tangible-Asset of 6.03% is 693.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Touchstone International Medical Science Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touchstone International Medical Science Co's current Return-on-Tangible-Asset is 6.03%, which is 48% below median its own 10-year median of 11.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touchstone International Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Touchstone International Medical Science Co (SHSE:688013) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.74, compared to a current price of ¥26.66 — trading 7.2% below its estimated fair value. The current Return-on-Tangible-Asset is 6.03%, which is 48% below median its 10-year median of 11.58 and 693.4% above the Medical Devices & Instruments industry median of 0.76. Touchstone International Medical Science Co's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Touchstone International Medical Science Co (SHSE:688013), the current Return-on-Tangible-Asset is 6.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touchstone International Medical Science Co (SHSE:688013) Overvalued in 2026?
Based on GuruFocus' analysis, Touchstone International Medical Science Co stock appears to be undervalued.
The current stock price of ¥26.66 is trading 7.2% below its estimated GF Value™ of ¥28.74.
GuruFocus considers Touchstone International Medical Science Co to be Fairly Valued.
Key valuation signals for SHSE:688013:
Return-on-Tangible-Asset: 6.03% (48% below median its 10-year median of 11.58)
GF Value™: ¥28.74 vs. price of ¥26.66 (7.2% below fair value)
Industry Position: 693.4% above the Medical Devices & Instruments median (#98 of 853)
No single metric tells the full story. See the SHSE:688013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
84GF Score
Get the complete analysis for SHSE:688013
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688013 has been successfully added to your 
